CL2008002174A1 - Proceso para preparar aminodioles de oxazolidina y oxazolidina; uno de los aminodioles protegidos que se obtiene; y uno de los compuestos intermediarios que se forma en los procesos descritos - Google Patents

Proceso para preparar aminodioles de oxazolidina y oxazolidina; uno de los aminodioles protegidos que se obtiene; y uno de los compuestos intermediarios que se forma en los procesos descritos

Info

Publication number
CL2008002174A1
CL2008002174A1 CL2008002174A CL2008002174A CL2008002174A1 CL 2008002174 A1 CL2008002174 A1 CL 2008002174A1 CL 2008002174 A CL2008002174 A CL 2008002174A CL 2008002174 A CL2008002174 A CL 2008002174A CL 2008002174 A1 CL2008002174 A1 CL 2008002174A1
Authority
CL
Chile
Prior art keywords
aminodiols
oxazolidine
preparing
protected
processes described
Prior art date
Application number
CL2008002174A
Other languages
English (en)
Inventor
James C Towson
Original Assignee
Schering Plough Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40019364&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2008002174(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Plough Ltd filed Critical Schering Plough Ltd
Publication of CL2008002174A1 publication Critical patent/CL2008002174A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/10—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D263/14—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with radicals substituted by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Proceso para preparar oxazolidina y oxazolidinona aminodioles; compuestos intermediarios, útil para preparar florfenicol.
CL2008002174A 2007-07-25 2008-07-24 Proceso para preparar aminodioles de oxazolidina y oxazolidina; uno de los aminodioles protegidos que se obtiene; y uno de los compuestos intermediarios que se forma en los procesos descritos CL2008002174A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US95181607P 2007-07-25 2007-07-25

Publications (1)

Publication Number Publication Date
CL2008002174A1 true CL2008002174A1 (es) 2008-11-21

Family

ID=40019364

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2008002174A CL2008002174A1 (es) 2007-07-25 2008-07-24 Proceso para preparar aminodioles de oxazolidina y oxazolidina; uno de los aminodioles protegidos que se obtiene; y uno de los compuestos intermediarios que se forma en los procesos descritos

Country Status (15)

Country Link
US (1) US20100210851A1 (es)
EP (1) EP2173726A2 (es)
JP (1) JP2010534667A (es)
KR (1) KR20100046217A (es)
CN (1) CN101796037A (es)
AR (1) AR068325A1 (es)
AU (1) AU2008279308A1 (es)
BR (1) BRPI0814581A2 (es)
CA (1) CA2693922A1 (es)
CL (1) CL2008002174A1 (es)
PE (1) PE20090505A1 (es)
RU (1) RU2010106607A (es)
TW (1) TW200925153A (es)
WO (1) WO2009015111A2 (es)
ZA (1) ZA201000397B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR044437A1 (es) * 2003-05-29 2005-09-14 Schering Plough Ltd Composiciones y metodo para el tratamiento de infecciones en ganado vacuno y porcino
EP2102154A1 (en) * 2006-12-13 2009-09-23 Schering-Plough Ltd. Water-soluble prodrugs of chloramphenicol, thiamphenicol, and analogs thereof
CN102131772B (zh) 2008-07-30 2015-03-11 英特威国际有限公司 用作氟苯尼考的中间体的*唑啉-保护的氨基二醇化合物的制备方法
WO2012150520A1 (en) 2011-05-02 2012-11-08 Pfizer Inc. Novel cephalosporins useful as antibacterial agents
CN108299330B (zh) * 2018-02-06 2021-02-12 桂林医学院 去氢枞酸噁唑烷酮衍生物及其制备方法和应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5105009A (en) * 1983-06-02 1992-04-14 Zambon S.P.A. Intermediates for the preparation of 1-(phenyl)-1-hydroxy-2-amino-3-fluoropropane derivatives
IT1237798B (it) * 1989-10-20 1993-06-17 Zambon Spa Processo per l'inversione stereochimica di (2s,3s)-2-ammino-3-fenil-1 ,3-propandioli nei corrispondenti enantiomeri (2r,3r).
IT1249048B (it) * 1991-02-21 1995-02-11 Zambon Spa Processo per la preparazione di trans-(5r)-2-ossazoline -2,4,5, trisostituite
US5663361A (en) * 1996-08-19 1997-09-02 Schering Corporation Process for preparing intermediates to florfenicol
US7126005B2 (en) * 2003-10-06 2006-10-24 Aurobindo Pharma Limited Process for preparing florfenicol
AU2006287697A1 (en) * 2005-09-07 2007-03-15 Schering-Plough Pty. Limited An improved process for preparing oxazolidine protected aminodiol compounds useful as intermediates to Florfenicol

Also Published As

Publication number Publication date
CN101796037A (zh) 2010-08-04
CA2693922A1 (en) 2009-01-29
WO2009015111A3 (en) 2009-03-26
JP2010534667A (ja) 2010-11-11
KR20100046217A (ko) 2010-05-06
WO2009015111A2 (en) 2009-01-29
AR068325A1 (es) 2009-11-11
PE20090505A1 (es) 2009-04-29
ZA201000397B (en) 2010-09-29
AU2008279308A1 (en) 2009-01-29
RU2010106607A (ru) 2011-08-27
BRPI0814581A2 (pt) 2017-05-09
WO2009015111A8 (en) 2010-03-04
TW200925153A (en) 2009-06-16
EP2173726A2 (en) 2010-04-14
US20100210851A1 (en) 2010-08-19

Similar Documents

Publication Publication Date Title
NO20081685L (no) Fremgangsmate for fremstilling oksazolidin-beskyttelse aminodolforbindelser anvendbare som mellomprodukter for Florfenicol
CL2008001562A1 (es) Proceso para la preparacion de compuestos de aminodiol protegidos con oxazolina; los compuestos intermediarios considerados; utiles como intermediarios en la preparacion de florfenicol.
CY1123164T1 (el) Διεργασια για τη συνθεση ενος αναστολεα ινδολαμινης 2,3-διοξυγενασης
BR112019003914A2 (pt) inibidores de processos metabólicos celulares
CO6400224A2 (es) Purificación de 1-[2-(2-4-dimetilfenilsulfanil)fenil]piperazina
EA200900441A1 (ru) Способы и интермедиаты для получения ингибиторов интегразы
AR052681A1 (es) Formas cristalinas de 2-(3-fluoro-4 hidroxifenil ) -7 -vinil-1,3- benzoxazol -5-ol
CL2012001171A1 (es) Procedimiento para la preparacion del ester n-[[2-[[[4-[[[(hexiloxicarbonil)]4-amino]iminometil]fenil]amino]metil]1-alquil-1h-benzimidazol-5-il]carbonil]n-2-piridinil-etilico de beta-alanina; y uno de los compuestos intermediarios considerados.
DOP2010000326A (es) Compuestos de tiazol y oxazol de bencen-sulfonamida
CL2009001214A1 (es) Compuestos derivados de heterociclo, moduladores de serina proteasas composicion fa<rmacaeutica que los comprende; y su uso en el tratamiento de trastornos tromboembolicos
UY30639A1 (es) Derivados sustituidos de 2h-ftalazin-1-ona, sus formas cristalinas, proceso de preparacion y aplicaciones
CL2008002998A1 (es) Compuestos derivados de piperazina-1-carboxamida, inhibidor de faah; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento del dolor inflamatorio o neuropatico, ansiedad y depresion.
NI201000098A (es) 4-fenilpiran-3,5-dionas, 4-feniltiopiran-3,5-dionas y 2-fenilciclohexan-1,3,5-trionas como herbicidas.
CL2008002174A1 (es) Proceso para preparar aminodioles de oxazolidina y oxazolidina; uno de los aminodioles protegidos que se obtiene; y uno de los compuestos intermediarios que se forma en los procesos descritos
EA201000269A1 (ru) Новые гербициды
EA200970605A1 (ru) Ингибиторы mapk/erk-киназ
EA201101146A1 (ru) Новые гербициды
BRPI0710199A2 (pt) Processo para preparação de inibidores de hiv protease
UY31479A1 (es) 5-[(3,3,3-trifluoro-2-hidroxi-1-arilpropil)amino]-1h-quinolin-2-onas, un proceso para su produccion y su uso como agentes antiinflamatorios
CL2008003095A1 (es) Procedeimiento de preparacion de dihidrotienopirimidas; uno de los compuestos intermediarios considerados; y el procedimiento de preparacion de dicho compuesto intermediario.
CL2016001172A1 (es) Nuevos inhibidores de dgat2.
BRPI0923178A2 (pt) derivados heterocíclicos de oxadiazol fundidos úteis para o tratamento de esclerose múltipla
BR112012013272A2 (pt) processo para a polimerização em massa do lactídeo
CL2010001441A1 (es) Proceso para la preparacion de derivados de 2-amino tiazolonas sustituidas utilizando derivados de efedrina como base quiral.
CU20090131A7 (es) Nuevo proceso de síntesis industrial de agomelatina